The Future of Healthcare
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In our focused therapeutic areas, our revolutionary technology, Simoa®, is helping researchers advance the science of precision health.
Learn more about the science behind Simoa®
Our digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers in a majority of therapeutic areas, including neurology, infectious disease, oncology, inflammation, and cardiology.
instruments
Delivering ultrasensitive biomarker measurement you can count on.
HD-X™ Automated Immunoassay Analyzer
Introducing the world’s most sensitive, fully automated immunoassay platform with multiplexing and custom assay capability.
1000x
Up to 1000x greater sensitivity
6 in 1
Up to 6 biomarkers in a single assay
80+
Compatible with 80+ assays
SP-X Imaging and Analysis System™
Unleashing the power of next-generation Simoa® Planar Array technology for robust multiplex biomarker detection – even at healthy baseline levels.
1000x
Up to 1000x greater sensitivity
10 in 1
Up to 10 biomarkers in a single assay
100+
Compatible with 100+ assays
SR-X™ Biomarker Detection System
Offers researchers access to ultra-sensitive biomarker detection capabilities in a compact and affordable system.
1000x
Up to 1000x greater sensitivity
6 in 1
Up to 6 biomarkers in a single assay
30+
Compatible with 30+ assays
2470 Arrayer
Produces high quality microarrays of DNA, proteins, cell lysates and a variety of other samples using its proprietary soft touch deposition technology.
Flexible
Unmatched sample flexibility
Versatile
Prints on a variety of surfaces
Quality
High density printing for accuracy
THERAPEUTIC AREAS
Precision science applied to the biology of health & disease
We’re committed to catalyzing the science first, with several hundred peer-reviewed science journal publications showcasing the impact the Simoa technology is making in the fields of oncology, neurology, cardiology, inflammation and infectious disease.
Over 170 Peer-reviewed oncology publications using Simoa® Technology
Single-plex and multiplex assays available to measure relevant oncology biomarkers in multiple sample types
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels
Assay kits measure up to 4 neurological targets simultaneously in blood or CSF
Over 500 peer-reviewed publications featuring Simoa® technology
Neurolgy research supported by Simoa® bead technology
Simoa® biomarker assays to facilitate the research on Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, TBI, and more
Commercially-available assay kits measure 17 individual cardiology targets in multiple sample types with precision and sensitivity
Use of ultrasensitive Simoa® bead and planar array platforms in cardiology studies supported by peer-reviewed research
Area of study supported by both Simoa® bead and planar array technologies
Ultrasensitive Simoa® bead and planar platforms facilitated over 150 peer-reviewed research publications
Assay kits measure key markers of inflammation in singleplex and multiplex configurations
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels
Over 100 peer-reviewed research articles in infectious diseases using Simoa®
Simoa® bead and planar technologies enable research on a range of infectious diseases, including HIV and COVID-19
Ultrasensitive singleplex and multiplex assays measure essential markers of disease activity and severity
Ultrasensitive bead and planar array platforms allow quantification of key targets at baseline and disease levels
The Evolution of the Immunoassay
Digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, Quanterix enables development of methods providing much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.
The technology is currently being used for applications in a majority of therapeutic areas, including oncology, neurology, cardiology, inflammation, and infectious disease.
Simoa® Accelerator Laboratory
The Simoa® Accelerator Laboratory is your go-to, CLIA-Licensed resource for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery. Gain instant access to Quanterix’ full suite of instruments and assays including the new next-generation Simoa planar platform with 10-plex assay capability. Propel your research further than any other contract research company by detecting proteins and nucleic acids at the lowest possible levels with Simoa capabilities.
Learn More